Meticulous Research® has published a detailed report titled “Pharmaceutical Packaging Market by Material (Polymer [PE, PP, PET], Glass, Paper, Metal), Type (Bottles, Blister, PFS, Caps, Vials, Ampoules, Sachet, Inhaler, Secondary, Tertiary), Dosage Form (Oral, Parenteral, Topical), End User - Global Forecast to 2031.”

According to this report, the global pharmaceutical packaging market is projected to reach $176.54 billion by 2031, growing at a CAGR of 7.6% from 2024 to 2031. The market's growth is driven by factors including the expansion of the pharmaceutical sector, increased demand for drug delivery devices, rising healthcare expenditures, a growing focus on biosimilars, and trends in contract manufacturing and packaging. The aging population and the increase in chronic diseases also contribute to this growth. However, challenges such as counterfeit packaging, waste from single-use products, and concerns about material safety could impede market progress.

Opportunities for market expansion include the rising adoption of personalized medicine and self-medication, improvements in healthcare in emerging economies, increased pharmaceutical R&D spending, and a heightened focus on vaccine development. Nevertheless, shifting regulatory requirements and evolving market demands present significant challenges.

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5298

Key Market Players
Key players in the global pharmaceutical packaging market include Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).

Market Segmentation and Insights

The market is segmented by material (Polymer, Glass, Paper & Paperboard, Metal, and Other Materials), packaging type (Primary, Secondary, Tertiary), dosage form (Oral, Parenteral, Other), and end user (Pharmaceutical Companies, Contract Companies, Pharmacies).
• Materials: The glass segment is anticipated to experience the highest CAGR due to increased use in pharmaceutical packaging and rising demand for vials and ampoules. Notably, Stoelzle Pharma (Austria) launched a new line of glass jars in October 2023, which are expected to contribute to this growth.
• Packaging Types: Primary packaging is expected to hold the largest market share in 2024. This dominance is driven by advancements in packaging technologies, including RFID, temperature-indicating inks, and NFC.
• Dosage Forms: The parenteral dosage form segment is projected to grow the fastest, driven by the development of advanced drug delivery devices such as pre-filled syringes and innovations in smart packaging.
• End Users: Pharmaceutical companies are expected to account for the largest market share in 2024 due to the increasing demand for medicines, a rise in chronic diseases, and a growing number of drugs in development.

Quick Buy – Pharmaceutical Packaging Market - Global Opportunity Analysis and Industry Forecast (2024-2031), Research Report: https://www.meticulousresearch.com/Checkout/28241997

Geographic Insights
The report covers major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to register the highest CAGR, with China leading the region due to increased pharmaceutical R&D investments and the government's Made in China (MIC) 2025 plan aimed at enhancing domestic manufacturing capabilities.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research